|
HS Code |
324984 |
| Chemicalname | 2-Hydroxy-3-Bromo-4-Methylpyridine |
| Molecularformula | C6H6BrNO |
| Molecularweight | 188.025 g/mol |
| Casnumber | 884494-29-1 |
| Appearance | White to off-white solid |
| Purity | Typically ≥97% |
| Solubility | Soluble in organic solvents like DMSO and methanol |
| Smiles | CC1=CC(=NC(=C1O)Br) |
| Inchikey | JIKQYGWWJRKQMA-UHFFFAOYSA-N |
| Storagetemperature | 2-8°C (Refrigerated) |
| Synonyms | 3-Bromo-4-methylpyridin-2-ol |
As an accredited 2-Hydroxy-3-Bromo-4-Methylpyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Hydroxy-3-Bromo-4-Methylpyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working in a lab for most of my career, I’ve watched countless building blocks pass through the benches—each compound bringing its own promise and quirks. Among these, 2-Hydroxy-3-Bromo-4-Methylpyridine has started to draw attention not just because of its unique structure, but also because of the way researchers and developers have begun weaving it into new applications. This compound, identified by its specific arrangement of hydroxy, bromo, and methyl groups on a pyridine ring, arrives as a valuable intermediate for many who seek to create more targeted molecules in pharmaceuticals, materials, and even specialty chemical projects.
From the outset, the presence of a hydroxy group at position two and a bromine at position three do more than fill up a chemical formula—they invite a set of reactions that can’t be easily executed with more common, less decorated pyridine rings. Developers who have tried upgrading classic routes with simple methylpyridine often find the results lacking in selectivity and accessibility for downstream modifications. Throwing 2-hydroxy and a ring-bromine into the mix, suddenly a handle appears for easier substitution and coupling, especially when the synthesist wants control over where new groups attach.
Specifications shape more than just the product delivered—they guide every step from planning to implementation. In the case of 2-Hydroxy-3-Bromo-4-Methylpyridine, a minimum purity benchmark above 98% ensures that users can work with confidence, reducing headaches from byproducts that usually show up during reactions. I’ve seen how higher purity material can cut down purification steps, especially when unwanted isomers and trace contaminants have a habit of clogging up columns or muddying analytical results. The material’s off-white, sometimes light tan, crystalline appearance often hints at batch stability, and proper packaging goes a long way toward safeguarding against moisture and sunlight, both of which can alter performance in the lab.
Beyond purity, careful attention lands on moisture content, residual solvents, and specific melting range. Chemists searching for reliable reactivity look for certainty in these parameters—swings in moisture, even a percent or two, can kickstart unwanted side reactions or drag yields below expectations. In projects where cost and time run tight, waiting for another crystallization or longer drying step often isn’t an option. Reliable 2-Hydroxy-3-Bromo-4-Methylpyridine reduces those incidents, so synthetic planning stays on schedule.
Individuals who build complex molecules or screening libraries often need “functional handles”—points in a molecule where reactions can be directed with high selectivity. The pairing of a hydroxy and bromo group on the pyridine skeleton makes this compound stand out as a “bifunctional” intermediate. Medicinal chemists have written about how derivatives crafted from this base get tested for antimicrobial, anti-inflammatory, and even neurological activity. In discovery teams I’ve joined, chemists quickly realized that swapping out the bromine atom with different nucleophiles expands the creative playbook, all while the hydroxy group opens the door for further acylation, alkylation, or even ether formation.
Industrial research teams synthesizing specialty polymers have also turned to 2-Hydroxy-3-Bromo-4-Methylpyridine, taking advantage of the molecule’s readiness for cross-coupling protocols. Whether using Suzuki, Sonogashira, or Buchwald-Hartwig routes, the compound’s bromo group responds reliably, producing modified pyridine units that can be strung together into new backbone architectures. While older intermediates either limited functionality or brought in unwanted side products, this molecule streamlines efforts, reducing the total number of steps before reaching the final product.
Comparing 2-Hydroxy-3-Bromo-4-Methylpyridine with other pyridine building blocks, the key differences stem from substitution pattern and resulting reactivity. A simple 4-methylpyridine offers a platform, but lacks the dual-functionality for more elaborate coupling or targeted manipulation. Substituting both a hydroxy and bromo group lets chemists switch tactics without having to change intermediates mid-stream. This fails with plain halopyridines or simple methyl variants—each might deliver in some reactions but fall flat when asked to perform double-duty in a single pathway.
Many labs I’ve worked in stuck with 2-bromopyridine or 4-methoxypyridine, trying to stretch what those scaffolds could do. The need for extra protection and deprotection steps, plus the trouble of getting regiochemistry right, started stacking up. The arrival of 2-Hydroxy-3-Bromo-4-Methylpyridine let teams skip over those complicated “work-arounds.” Direct transformations became possible in fewer steps, while the methyl group at position four often improved solubility over unsubstituted equivalents, making the compound easier to handle during large-scale operations.
Quality control isn’t just paperwork in development cycles—it serves as a safeguard for both reproducibility and team safety. Testing protocols typically involve NMR and HPLC, pinpointing even the smallest impurities. Risk of cross-contamination with other halogenated pyridines can complicate analysis, so most reputable suppliers invest in well-maintained facilities and transparent documentation. Having had my share of issues with poorly tracked supply chains, I’ve learned that consistent sourcing from responsible channels shields teams from repeat headaches.
Handling specifics deserve mention, too. That bromine atom, helpful as a leaving group in many reactions, also demands respect due to its potential for hazardous byproduct release. Fume hoods, gloves, and solid waste controls keep both people and projects safe. I once saw the damage from ignoring proper ventilation during a coupling run—the lesson stuck. Teams looking to scale up quickly move beyond general precautions, mapping out emergency plans and exposure controls before the first gram is weighed out.
The literature supports much of what practical labs have discovered. Several studies in the Journal of Medicinal Chemistry document the use of hydroxy- and bromo-substituted pyridines as pivotal intermediates, reporting high conversion rates and selectivity in routes targeting new pharmaceuticals. Industrial-scale reactions published in Organic Process Research & Development repeat this finding; 2-Hydroxy-3-Bromo-4-Methylpyridine reacts predictably under palladium-catalyzed conditions, allowing for diverse functionalization without the erratic side reactions that plague less robust intermediates.
Colleagues at scale-up facilities echo these findings, describing reductions in waste and overall process time when switching to this compound as an intermediate. Waste stream analysis has shown lower halogenated byproduct formation, leading to easier downstream water treatment and fewer regulatory complications. This fact alone bolsters its value in settings where process economics and environmental controls pull equal weight.
Despite its strengths, working with 2-Hydroxy-3-Bromo-4-Methylpyridine isn’t always seamless. Stability during long-term storage sometimes causes concern, especially in environments prone to humidity or temperature swings. Experiments suggest that storing the compound in airtight glass under desiccant and limiting exposure to light can preserve its integrity well past standard shelf life—simple steps that every lab can implement without extra cost.
Supply chain disruptions, especially in years marked by global uncertainty, have also complicated acquisition. Sourcing from vendors who maintain stock domestically reduces transit risks. Building relationships with local or regional suppliers gives teams a buffer against international shipping delays and sudden shortages—a strategy that saved one of our projects during a freight strike that held up imports overseas for weeks on end.
Waste disposal always comes up with halogenated intermediates. Companies that invest in proper neutralization systems—treating aqueous and solid remnants before release—reduce environmental risk and regulatory fines. Working with environmental health and safety experts to draft and enforce disposal protocols pays off, avoiding the costs and ethical lapses of improper handling. In one facility I joined, a collaborative audit between R&D and EHS prevented thousands in potential fines and set new best practices for the group.
Another area of improvement comes in documentation and traceability. Even a well-characterized batch can lose value if proper records vanish or get muddled in translation. Team efforts focused on maintaining clear batch logs, including detailed synthetic origin and testing dates. Not only did this foster trust with auditors, but it also let the group troubleshoot anomalies with far more speed—catching issues before they turned into expensive downtime or lost product.
Modern research doesn’t slow down, and the trend toward complexity in pharmaceutical and materials development leans on intermediates like 2-Hydroxy-3-Bromo-4-Methylpyridine. The next wave of drug design, built on small modifications to core scaffolds, calls for flexible intermediates with reliable reactivity. As green chemistry becomes less a buzzword and more a basic requirement, the drive continues to adapt existing protocols to cut down on hazardous waste, improve catalyst turnover, and reuse solvents whenever possible.
Collaborative consortia between academic labs and industry drive many of these advances. Sharing batch reactivity data, failure reports, and best handling practices lets teams not just save on costs, but also accelerate timelines to deliver real-world therapies and new functional materials. I’ve seen how transparent communication between research groups speeds collective understanding far beyond what any single lab could achieve alone. Several university partnerships highlight 2-Hydroxy-3-Bromo-4-Methylpyridine as a model substrate for cutting-edge reaction development, especially in small-volume, high-throughput screening.
The trend toward multifunctional intermediates reshapes how teams tackle both early- and late-stage synthesis. Having a single molecule capable of delivering two, even three, selective transformations reduces both time and monetary cost. More labs look to streamline synthesis, cut down on solvent use, and sidestep needlessly complex protection-deprotection cycles. The advantages seen with 2-Hydroxy-3-Bromo-4-Methylpyridine fit squarely into this evolution. Feedback loops between users and suppliers continue to improve product quality. End users sometimes request custom purifications, and feedback from these real-world applications influences both supply chain decisions and on-the-ground laboratory practices.
Looking back over two decades in chemical research and development, the rise of better intermediates drives more than just a technical change. These compounds accelerate problem solving, promote teamwork, and move the field toward more thoughtful stewardship of resources. The successes—and the workable setbacks—add to a communal base of knowledge, pushing the industry ahead. In more than one instance, a challenging project has turned around following the adoption of a smarter intermediate. Teams benefit, and projects move from bench to production with fewer detours.
Any tool used without understanding can become a liability. Experienced labs approach new intermediates with careful review, not just a cursory glance at a web page or catalog entry. Before integrating 2-Hydroxy-3-Bromo-4-Methylpyridine into a multi-step process, successful researchers test for compatibility and safety in small-scale runs, logging findings into internal databases. This attention to detail builds reliability and confidence over time. Encouraging open discussion of both good and bad results helps everyone make more informed decisions. Choosing products with a robust test record and consistent supply history makes sense, protecting both projects and people from unpleasant surprises.
Sharing tips learned from practical mistakes—overdried samples leading to reduced solubility, or bottlenecks from supplier mislabeling—keeps knowledge moving forward. The more collective learning becomes part of ongoing training and protocol development, the better positioned teams become to use intermediates like 2-Hydroxy-3-Bromo-4-Methylpyridine as planned, rather than simply reacting to surprises midstream.
Pressures mount to cut waste and boost throughput, and the adoption of intermediates designed for minimal side reactions cuts away at the traditional hassle of workups. Several colleagues report adopting more robust tracking systems at every synthetic stage, enabling instant review of compound history, storage outcomes, and waste streams. Automated systems for weighing and dispensing, when paired with clear digital logs, reduce both user error and unintended contamination. Several companies now push for cradle-to-grave auditing—tracing each gram from order to final waste disposal.
Environmental sustainability also gets a boost from compounds that require fewer hazardous reagents or enable milder conditions. If a key intermediate enables a critical transformation without using heavy metals or excess acids, both environment and bottom line improve. This approach echoes in almost every modern process development meeting, and chemical suppliers feel the pressure to keep up. With ongoing improvements in production and distribution, 2-Hydroxy-3-Bromo-4-Methylpyridine exemplifies the shift toward more responsible chemistry.
Every development, from the smallest research lab to the largest production facility, depends on the quality and flexibility of its building blocks. The arrival and adoption of 2-Hydroxy-3-Bromo-4-Methylpyridine across multiple sectors speaks to the growing demand for adaptable, reliable intermediates. With a track record rooted in published research, regular feedback from hands-on practitioners, and growing support from suppliers, this compound sets itself apart not just through its structure, but through its wide-ranging usability and practical benefits.
Staying informed about both the advantages and challenges of each new intermediate supports safer, more successful research and production. Teams that foster shared learning, maintain stringent documentation, and choose suppliers wisely will continue to unlock the full potential of compounds like 2-Hydroxy-3-Bromo-4-Methylpyridine. This ongoing conversation—between bench chemists, process engineers, safety officers, and educators—drives more effective and sustainable innovation. As the spotlight shifts from older, less flexible building blocks, those willing to embrace and share lessons learned from practical, real-world adoption will define the next era of synthetic and applied chemistry.